» Articles » PMID: 36093076

The Etiology and Pathogenesis of Type 1 Diabetes - A Personal, Non-systematic Review of Possible Causes, and Interventions

Overview
Specialty Endocrinology
Date 2022 Sep 12
PMID 36093076
Authors
Affiliations
Soon will be listed here.
Abstract

In this review after a lifelong research career, my personal opinion on the development of type 1 diabetes (T1D) from its very start to clinical manifestation will be described. T1D is a disease of an increased intestinal permeability and a reduced pancreas volume. I am convinced that virus might be the initiator and that this virus could persist on strategically significant locations. Furthermore, intake of gluten is important both in foetal life and at later ages. Disturbances in sphingolipid metabolism may also be of crucial importance. During certain stages of T1D, T cells take over resulting in the ultimate destruction of beta cells, which manifests T1D as an autoimmune disease. Several preventive and early treatment strategies are mentioned. All together this review has more new theories than usually, and it might also be more speculative than ordinarily. But without new ideas and theories advancement is difficult, even though everything might not hold true during the continuous discovery of the etiology and pathogenesis of T1D.

Citing Articles

Comparison of pediatric diabetic ketoacidosis in newly diagnosed versus known patients with type 1 diabetes mellitus: A single-center study.

Alsolaimani N, Kattan M, Algabbani Z, Awlia G, Alhamdani Y, AlAgha A Saudi Med J. 2024; 45(12):1326-1333.

PMID: 39658119 PMC: 11629648. DOI: 10.15537/smj.2024.45.12.20240734.


Early Onset of Type 1 Diabetes in Kuwait: Distinct Clinical, Metabolic, and Immunological Characteristics.

Al-Abdulrazzaq D, Qabazard M, Al-Jasser F, Al-Anizi A, Al-Basari I, Mandani F Med Princ Pract. 2024; 33(6):555-561.

PMID: 39097968 PMC: 11631037. DOI: 10.1159/000540705.


Applications of Genome-Editing Technologies for Type 1 Diabetes.

El Nahas R, Al-Aghbar M, Herrero L, van Panhuys N, Espino-Guarch M Int J Mol Sci. 2024; 25(1).

PMID: 38203514 PMC: 10778854. DOI: 10.3390/ijms25010344.


Challenges and opportunities in the islet transplantation microenvironment: a comprehensive summary of inflammatory cytokine, immune cells, and vascular endothelial cells.

Chen Q, Liu L, Zhao X, Liang J, Li S Front Immunol. 2023; 14:1293762.

PMID: 38111575 PMC: 10725940. DOI: 10.3389/fimmu.2023.1293762.


Melatonin ameliorates high glucose-induced autophagy in Schwann cells.

Salem H, Chok K, Koh R, Ng P, Tiong Y, Chye S Int J Biochem Mol Biol. 2023; 14(3):25-31.

PMID: 37456910 PMC: 10349298.


References
1.
Patterson C, Harjutsalo V, Rosenbauer J, Neu A, Cinek O, Skrivarhaug T . Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study. Diabetologia. 2018; 62(3):408-417. DOI: 10.1007/s00125-018-4763-3. View

2.
Rowe R, Leslie R . Twin studies in insulin dependent diabetes and other autoimmune diseases. Diabetes Metab Rev. 1995; 11(2):121-35. DOI: 10.1002/dmr.5610110204. View

3.
Herold K, Bundy B, Long S, Bluestone J, DiMeglio L, Dufort M . An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med. 2019; 381(7):603-613. PMC: 6776880. DOI: 10.1056/NEJMoa1902226. View

4.
Xu P, Cuthbertson D, Greenbaum C, Palmer J, Krischer J . Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care. 2007; 30(9):2314-20. DOI: 10.2337/dc06-2389. View

5.
Lammers K, Lu R, Brownley J, Lu B, Gerard C, Thomas K . Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology. 2008; 135(1):194-204.e3. PMC: 2653457. DOI: 10.1053/j.gastro.2008.03.023. View